Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 8.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1999 to 2008

Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 907 888 861 881 847 864 884 905 840 820
With Immunosuppression Info 907 886 861 881 844 851 879 891 831 815
Corticosteroids Any in Category 97.9% 97.1% 93.3% 89.6% 83.8% 75.2% 71.0% 66.2% 65.5% 70.1%
Prednisone 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Steroids 97.9% 97.0% 93.3% 89.6% 83.8% 75.2% 71.0% 66.2% 65.5% 70.1%
Cyclosporine Any in Category 23.3% 18.8% 13.7% 9.8% 8.9% 6.2% 6.7% 6.4% 4.5% 4.4%
Sandimmmune 2.4% 1.9% 0.9% 0.8% 0.1% 0.1% 0.2% 0.2% 0.2% 0.5%
Neoral 20.7% 16.1% 10.8% 6.8% 7.2% 5.3% 5.2% 5.4% 3.7% 3.7%
Gengraf 0.1% 0.8% 2.0% 1.9% 1.5% 0.8% 1.3% 0.8% 0.5% 0.2%
Eon 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 75.3% 82.3% 86.6% 90.2% 83.9% 84.6% 88.9% 92.1% 93.9% 93.3%
Tacrolimus 75.3% 82.3% 86.6% 90.2% 83.9% 84.6% 88.9% 92.1% 93.9% 93.3%
Antimetabolites Any in Category 92.7% 84.9% 79.9% 82.1% 82.7% 83.7% 81.8% 85.1% 91.3% 91.2%
Mycophenolate Mofetil 89.4% 82.4% 78.9% 81.0% 81.6% 81.8% 74.6% 71.6% 73.4% 72.5%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 1.5% 6.9% 12.3% 17.2% 18.5%
Azathioprine 3.3% 2.5% 1.0% 1.0% 1.1% 0.4% 0.2% 1.1% 0.7% 0.1%
Cytoxan 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 1.2% 13.2% 21.4% 19.0% 19.3% 16.8% 15.4% 16.3% 10.3% 8.0%
Sirolimus 1.0% 13.0% 21.4% 19.0% 19.2% 16.8% 15.4% 16.3% 10.3% 8.0%
Everolimus 0.2% 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 4, 2009.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.



PDF FormatRequires Adobe Acrobat Reader